Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

162
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Size-dependence of food intake and mortality interact with temperature and seasonality to drive diversity in fish life histories.

Evolutionary applications·2024
Same author

Population processes in cyber system variability.

PloS one·2022
Same author

Reproductive hyperallometry and managing the world's fisheries.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same author

Modeling optimal responses and fitness consequences in a changing Arctic.

Global change biology·2019

Related Experiment Video

Updated: Aug 10, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K

Operational analysis for COVID-19 testing: Determining the risk from asymptomatic infections.

Marc Mangel1,2,3

  • 1Department of Biology, University of Bergen, Bergen, Norway.

Plos One
|February 13, 2023
PubMed
Summary

Testing accuracy during pandemics is crucial. This study presents a method to translate observed positive test rates into true infection incidence, accounting for asymptomatic cases and informing risk assessment in groups.

More Related Videos

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.6K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

849

Related Experiment Videos

Last Updated: Aug 10, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.6K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

849

Area of Science:

  • Epidemiology
  • Public Health Policy
  • Mathematical Modeling

Background:

  • Pandemic health management relies heavily on testing.
  • Test inaccuracies (false positives/negatives) create a gap between observed and true infection rates.

Purpose of the Study:

  • To illustrate and extend a method for estimating true disease incidence from observed test positivity.
  • To incorporate asymptomatic infections into testing models.
  • To refine risk assessment for group testing strategies.

Main Methods:

  • Utilized analytical methods and Monte Carlo simulations to model the testing process.
  • Developed a framework to translate surface positivity to incidence rate estimates.
  • Extended the model to include asymptomatic infections and symptom status.

Main Results:

  • Demonstrated that observed positivity rate differs from true incidence rate.
  • Showed that symptom status and time since exposure provide valuable data for accurate estimates.
  • Established that risk is a continuous function of group size, not binary.
  • Identified the potential for over-testing in fixed regions due to diminishing returns of increased testing.

Conclusions:

  • Positivity rate is not a direct measure of incidence rate.
  • Symptom status and exposure history are critical for refining epidemiological estimates.
  • Risk assessment and testing strategies must consider group size and the potential for diminishing returns.